These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 34103686)
1. CDCA2 protects against oxidative stress by promoting BRCA1-NRF2 signaling in hepatocellular carcinoma. Wang S; Cao K; Liao Y; Zhang W; Zheng J; Li X; Huang M; Zhong Y; Hu X; Chen D; Wang Y Oncogene; 2021 Jun; 40(25):4368-4383. PubMed ID: 34103686 [TBL] [Abstract][Full Text] [Related]
2. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway. Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108 [TBL] [Abstract][Full Text] [Related]
3. Oxidative stress indicated by elevated expression of Nrf2 and 8-OHdG promotes hepatocellular carcinoma progression. Ma-On C; Sanpavat A; Whongsiri P; Suwannasin S; Hirankarn N; Tangkijvanich P; Boonla C Med Oncol; 2017 Apr; 34(4):57. PubMed ID: 28281193 [TBL] [Abstract][Full Text] [Related]
4. SLC27A5 deficiency activates NRF2/TXNRD1 pathway by increased lipid peroxidation in HCC. Gao Q; Zhang G; Zheng Y; Yang Y; Chen C; Xia J; Liang L; Lei C; Hu Y; Cai X; Zhang W; Tang H; Chen Y; Huang A; Wang K; Tang N Cell Death Differ; 2020 Mar; 27(3):1086-1104. PubMed ID: 31367013 [TBL] [Abstract][Full Text] [Related]
5. CDCA2 triggers in vivo and in vitro proliferation of hepatocellular carcinoma by activating the AKT/CCND1 signaling. Li J; Chen Y; Wang X; Wang C J BUON; 2021; 26(3):882-888. PubMed ID: 34268949 [TBL] [Abstract][Full Text] [Related]
6. CDCA2 Promotes HCC Cells Development via AKT-mTOR Pathway. Li K; Fan T; Shi Z; Jiang H Anal Cell Pathol (Amst); 2022; 2022():9912254. PubMed ID: 36588796 [TBL] [Abstract][Full Text] [Related]
7. Modulation of Nqo1 activity intercepts anoikis resistance and reduces metastatic potential of hepatocellular carcinoma. Shimokawa M; Yoshizumi T; Itoh S; Iseda N; Sakata K; Yugawa K; Toshima T; Harada N; Ikegami T; Mori M Cancer Sci; 2020 Apr; 111(4):1228-1240. PubMed ID: 31968140 [TBL] [Abstract][Full Text] [Related]
8. Cell division cycle associated 2 (CDCA2) upregulation promotes the progression of hepatocellular carcinoma in a p53-dependant manner. Wang J; Liu X; Chu H; Chen J PeerJ; 2022; 10():e13535. PubMed ID: 35694386 [TBL] [Abstract][Full Text] [Related]
9. NRF2 SUMOylation promotes de novo serine synthesis and maintains HCC tumorigenesis. Guo H; Xu J; Zheng Q; He J; Zhou W; Wang K; Huang X; Fan Q; Ma J; Cheng J; Mei W; Xing R; Cai R Cancer Lett; 2019 Dec; 466():39-48. PubMed ID: 31546024 [TBL] [Abstract][Full Text] [Related]
10. S-1-propenylmercaptocysteine protects murine hepatocytes against oxidative stress via persulfidation of Keap1 and activation of Nrf2. Tocmo R; Parkin K Free Radic Biol Med; 2019 Nov; 143():164-175. PubMed ID: 31349040 [TBL] [Abstract][Full Text] [Related]
11. Activation of AKT pathway by Nrf2/PDGFA feedback loop contributes to HCC progression. Liu D; Zhang Y; Wei Y; Liu G; Liu Y; Gao Q; Zou L; Zeng W; Zhang N Oncotarget; 2016 Oct; 7(40):65389-65402. PubMed ID: 27588483 [TBL] [Abstract][Full Text] [Related]
14. Induction of Oxidative Stress Through Inhibition of Thioredoxin Reductase 1 Is an Effective Therapeutic Approach for Hepatocellular Carcinoma. Lee D; Xu IM; Chiu DK; Leibold J; Tse AP; Bao MH; Yuen VW; Chan CY; Lai RK; Chin DW; Chan DF; Cheung TT; Chok SH; Wong CM; Lowe SW; Ng IO; Wong CC Hepatology; 2019 Apr; 69(4):1768-1786. PubMed ID: 30561826 [TBL] [Abstract][Full Text] [Related]
15. Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) in autophagy-induced hepatocellular carcinoma. Zhou J; Zhang X; Tang H; Yu J; Zu X; Xie Z; Yang X; Hu J; Tan F; Li Q; Lei X Clin Chim Acta; 2020 Jul; 506():1-8. PubMed ID: 32109431 [TBL] [Abstract][Full Text] [Related]
16. FGF19 Protects Hepatocellular Carcinoma Cells against Endoplasmic Reticulum Stress via Activation of FGFR4-GSK3β-Nrf2 Signaling. Teng Y; Zhao H; Gao L; Zhang W; Shull AY; Shay C Cancer Res; 2017 Nov; 77(22):6215-6225. PubMed ID: 28951455 [TBL] [Abstract][Full Text] [Related]
17. Increased CDCA2 Level Was Related to Poor Prognosis in Hepatocellular Carcinoma and Associated With Up-Regulation of Immune Checkpoints. Tang M; Liao M; Ai X; He G Front Med (Lausanne); 2021; 8():773724. PubMed ID: 35372372 [TBL] [Abstract][Full Text] [Related]
18. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma. Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861 [TBL] [Abstract][Full Text] [Related]
19. Cadmium telluride quantum dots cause oxidative stress leading to extrinsic and intrinsic apoptosis in hepatocellular carcinoma HepG2 cells. Nguyen KC; Willmore WG; Tayabali AF Toxicology; 2013 Apr; 306():114-23. PubMed ID: 23485651 [TBL] [Abstract][Full Text] [Related]
20. MCUR1 facilitates epithelial-mesenchymal transition and metastasis via the mitochondrial calcium dependent ROS/Nrf2/Notch pathway in hepatocellular carcinoma. Jin M; Wang J; Ji X; Cao H; Zhu J; Chen Y; Yang J; Zhao Z; Ren T; Xing J J Exp Clin Cancer Res; 2019 Mar; 38(1):136. PubMed ID: 30909929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]